Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Adding Ivabradine in Patients With Cardiogenic Shock Requiring Inotropic Support

NCT05594342 is registered in ClinicalTrials.gov with The Young Investigator Group of Cardiovascular Research as lead sponsor.

NCT NCT05594342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05594342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Adding Ivabradine in Patients With Cardiogenic Shock Requiring Inotropic Support
Lead sponsor
The Young Investigator Group of Cardiovascular Research
Phase
Phase 3
Overall status
Unknown status
Start date
July 1, 2022
Completion date
January 1, 2023
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiogenic shock, heart failure, ischemic heart disease